Header Logo

Carolina Ionete

Concepts (229)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
22
2024
208
4.130
Why?
Multiple Sclerosis, Relapsing-Remitting
11
2024
32
1.610
Why?
Proteomics
1
2024
256
0.820
Why?
Biomarkers
3
2024
1198
0.700
Why?
Cerebellar Diseases
1
2020
9
0.690
Why?
Immunoglobulins, Intravenous
1
2020
32
0.680
Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
18
0.670
Why?
Infectious Mononucleosis
1
2020
35
0.670
Why?
Intracranial Thrombosis
1
2019
27
0.660
Why?
Epstein-Barr Virus Infections
1
2020
90
0.630
Why?
Venous Thrombosis
1
2019
107
0.620
Why?
Dystonia
1
2018
13
0.610
Why?
Sjogren's Syndrome
1
2018
26
0.600
Why?
Antibodies, Monoclonal, Humanized
4
2020
220
0.570
Why?
Multiple Sclerosis, Chronic Progressive
4
2024
14
0.550
Why?
Central Nervous System Diseases
2
2016
56
0.510
Why?
Arthritis, Juvenile
1
2015
8
0.500
Why?
Etanercept
1
2015
31
0.500
Why?
Immunosuppressive Agents
4
2020
303
0.490
Why?
Sarcoidosis
1
2015
28
0.480
Why?
Uveitis
1
2015
30
0.480
Why?
White Matter
3
2023
111
0.460
Why?
Olivary Nucleus
1
2013
3
0.440
Why?
Thrombocytopenia
1
2014
48
0.440
Why?
Bipolar Disorder
1
2016
254
0.440
Why?
Cognition Disorders
1
2015
218
0.440
Why?
Magnetic Resonance Imaging
9
2024
2038
0.430
Why?
Positron-Emission Tomography
4
2024
173
0.430
Why?
Central Nervous System Neoplasms
1
2013
38
0.430
Why?
Lymphoma
1
2013
99
0.410
Why?
Antirheumatic Agents
1
2015
213
0.410
Why?
Tumor Necrosis Factor-alpha
1
2015
582
0.400
Why?
Humans
39
2024
59471
0.380
Why?
Receptors, GABA
2
2024
12
0.370
Why?
Middle Aged
19
2024
16259
0.370
Why?
Quality of Life
2
2023
1118
0.360
Why?
Adult
17
2024
15771
0.350
Why?
Male
21
2024
27561
0.340
Why?
Female
22
2024
30895
0.320
Why?
Pyrimidines
2
2019
121
0.280
Why?
Cross-Sectional Studies
4
2024
2473
0.280
Why?
Biomedical Research
2
2022
250
0.260
Why?
Diagnosis, Differential
3
2019
904
0.260
Why?
Immunologic Factors
3
2020
99
0.260
Why?
Meninges
1
2024
10
0.230
Why?
Alemtuzumab
4
2023
10
0.190
Why?
Inflammation
2
2019
1097
0.190
Why?
Cerebellum
2
2019
94
0.180
Why?
Biosensing Techniques
1
2022
114
0.180
Why?
Phenotype
1
2024
1150
0.180
Why?
Dimethyl Fumarate
1
2020
8
0.180
Why?
Familial Mediterranean Fever
1
2020
9
0.180
Why?
Crotonates
1
2020
3
0.180
Why?
Toluidines
1
2020
3
0.180
Why?
Immunoglobulin G
2
2020
452
0.180
Why?
Phosphate-Binding Proteins
1
2020
18
0.180
Why?
Cytokines
1
2024
905
0.180
Why?
Encephalomyelitis, Autoimmune, Experimental
1
2020
58
0.170
Why?
Microglia
2
2023
227
0.170
Why?
Pyroptosis
1
2020
31
0.170
Why?
Young Adult
6
2020
4321
0.170
Why?
Cysteine
1
2020
109
0.170
Why?
Immunoglobulin M
1
2020
112
0.170
Why?
Movement
1
2020
146
0.160
Why?
Anticonvulsants
1
2019
95
0.160
Why?
Seizures
1
2019
118
0.160
Why?
Raynaud Disease
1
2018
4
0.150
Why?
Urinary Bladder, Neurogenic
1
2018
4
0.150
Why?
Salivary Glands, Minor
1
2018
3
0.150
Why?
Alcoholism
1
2021
307
0.150
Why?
Primary Dysautonomias
1
2018
7
0.150
Why?
Neuralgia
1
2018
20
0.150
Why?
Sensation Disorders
1
2018
21
0.150
Why?
Physicians
1
2023
437
0.150
Why?
Antibodies, Antinuclear
1
2018
36
0.150
Why?
Syncope
1
2018
42
0.150
Why?
Intracellular Signaling Peptides and Proteins
1
2020
324
0.150
Why?
CD8-Positive T-Lymphocytes
1
2023
646
0.150
Why?
Aged
10
2024
13342
0.150
Why?
Migraine Disorders
1
2018
45
0.150
Why?
Antibodies, Viral
1
2020
305
0.150
Why?
Natalizumab
2
2014
11
0.150
Why?
Neuroimaging
1
2019
130
0.150
Why?
Cohort Studies
3
2020
2443
0.140
Why?
Fatal Outcome
2
2016
113
0.140
Why?
Antibodies, Monoclonal, Murine-Derived
2
2014
60
0.140
Why?
Coronavirus Infections
1
2020
187
0.140
Why?
Pneumonia, Viral
1
2020
199
0.140
Why?
Rituximab
2
2014
82
0.140
Why?
Patient Care Planning
1
2017
84
0.140
Why?
Basigin
1
2016
3
0.140
Why?
Mothers
1
2020
261
0.140
Why?
Gray Matter
1
2016
26
0.140
Why?
Lymphoma, Non-Hodgkin
1
2016
51
0.130
Why?
Interview, Psychological
1
2016
77
0.130
Why?
Tertiary Care Centers
1
2016
102
0.130
Why?
Brain
3
2023
1488
0.130
Why?
Immunoglobulin Heavy Chains
1
2015
42
0.120
Why?
Molecular Diagnostic Techniques
1
2015
29
0.120
Why?
Patient Participation
1
2017
211
0.120
Why?
Infliximab
1
2015
55
0.120
Why?
Comorbidity
2
2016
1090
0.120
Why?
Psychotic Disorders
1
2016
151
0.120
Why?
Methotrexate
1
2015
76
0.120
Why?
Interferon beta-1a
3
2020
9
0.120
Why?
DNA Mutational Analysis
1
2015
194
0.120
Why?
Body Fluids
1
2014
21
0.120
Why?
Prevalence
2
2016
1284
0.120
Why?
Research Report
1
2014
28
0.120
Why?
Methylprednisolone
1
2014
31
0.120
Why?
Glycogen Storage Disease Type IV
1
2014
2
0.110
Why?
Glycogen Debranching Enzyme System
1
2014
3
0.110
Why?
Prednisone
1
2014
80
0.110
Why?
Self Report
1
2016
367
0.110
Why?
Neuronal Plasticity
1
2015
141
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2015
251
0.110
Why?
Health Personnel
1
2017
343
0.110
Why?
Hypertrophy
1
2013
30
0.110
Why?
Decision Making
1
2017
391
0.110
Why?
Nucleosomes
1
2015
185
0.110
Why?
Brain Neoplasms
1
2016
306
0.110
Why?
Nervous System Diseases
1
2014
97
0.110
Why?
Muscle Weakness
1
2012
29
0.100
Why?
Anti-Inflammatory Agents
1
2014
159
0.100
Why?
Muscular Atrophy, Spinal
1
2012
21
0.100
Why?
Histones
1
2015
463
0.100
Why?
Gene Expression Regulation, Developmental
1
2015
630
0.090
Why?
Chromatin
1
2015
594
0.090
Why?
Practice Guidelines as Topic
1
2014
705
0.090
Why?
Neurons
1
2015
860
0.080
Why?
Treatment Outcome
2
2020
5174
0.080
Why?
Leukocytes, Mononuclear
2
2023
237
0.080
Why?
Recurrence
2
2023
577
0.080
Why?
Depressive Disorder, Major
1
2011
258
0.070
Why?
Multimodal Imaging
2
2019
66
0.070
Why?
Follow-Up Studies
3
2020
2327
0.070
Why?
HIV Infections
1
2012
920
0.060
Why?
Case-Control Studies
2
2020
1055
0.060
Why?
Child
3
2020
4308
0.060
Why?
Acetamides
1
2024
13
0.060
Why?
Enzyme-Linked Immunosorbent Assay
2
2016
448
0.060
Why?
Prospective Studies
2
2023
3096
0.060
Why?
Interferon-beta
2
2014
76
0.060
Why?
Pyridines
1
2024
98
0.050
Why?
Blood Proteins
1
2023
72
0.050
Why?
Antigens, CD20
1
2023
14
0.050
Why?
Myelin Sheath
1
2023
35
0.050
Why?
Metabolome
1
2022
24
0.050
Why?
Cerebral Cortex
1
2024
253
0.050
Why?
Plasma
1
2022
33
0.050
Why?
Gadolinium
1
2023
102
0.050
Why?
Albumins
1
2022
32
0.050
Why?
Fatigue
1
2023
104
0.050
Why?
Neuropsychological Tests
1
2023
340
0.050
Why?
Social Class
1
2021
123
0.050
Why?
Flow Cytometry
1
2023
638
0.050
Why?
T-Lymphocytes
2
2016
964
0.040
Why?
Citric Acid Cycle
1
2020
26
0.040
Why?
Hydroxybutyrates
1
2020
9
0.040
Why?
Nitriles
1
2020
57
0.040
Why?
Macrophage Activation
1
2020
119
0.040
Why?
Anthropometry
1
2020
80
0.040
Why?
Mice, Mutant Strains
1
2020
304
0.040
Why?
Foot
1
2020
40
0.040
Why?
Hand
1
2020
65
0.040
Why?
Lower Extremity
1
2021
145
0.040
Why?
Caspases
1
2020
164
0.040
Why?
Walking
1
2021
229
0.040
Why?
Severity of Illness Index
2
2016
1449
0.040
Why?
Protein Processing, Post-Translational
1
2020
255
0.040
Why?
Mental Health
1
2021
350
0.040
Why?
Betacoronavirus
1
2020
160
0.040
Why?
HEK293 Cells
1
2020
575
0.040
Why?
Algorithms
1
2023
992
0.040
Why?
Disease Progression
2
2014
1046
0.040
Why?
Patient Acceptance of Health Care
1
2021
448
0.040
Why?
Lipopolysaccharides
1
2020
645
0.030
Why?
Retrospective Studies
2
2022
6007
0.030
Why?
Patient Preference
1
2017
76
0.030
Why?
Cluster Analysis
1
2017
251
0.030
Why?
CD28 Antigens
1
2016
59
0.030
Why?
Inflammasomes
1
2020
331
0.030
Why?
Logistic Models
1
2020
1251
0.030
Why?
Clinical Decision-Making
1
2017
141
0.030
Why?
Focus Groups
1
2017
293
0.030
Why?
Antibodies
1
2016
176
0.030
Why?
Pandemics
1
2020
609
0.030
Why?
Multigene Family
1
2015
93
0.030
Why?
Frontal Lobe
1
2015
65
0.030
Why?
Infant
1
2020
1523
0.030
Why?
Adolescent
2
2016
5917
0.030
Why?
Fetus
1
2015
97
0.030
Why?
Socioeconomic Factors
1
2017
782
0.030
Why?
Animals
3
2020
19649
0.030
Why?
Macrophages
1
2020
1004
0.030
Why?
Mice
2
2020
10274
0.030
Why?
Patient-Centered Care
1
2017
249
0.030
Why?
JC Virus
1
2014
23
0.030
Why?
Genetic Carrier Screening
1
2014
14
0.030
Why?
Polyomavirus Infections
1
2014
46
0.030
Why?
Lymphocyte Activation
1
2016
739
0.030
Why?
Homozygote
1
2014
116
0.030
Why?
Spinocerebellar Ataxias
1
2014
13
0.030
Why?
Leukoencephalopathies
1
2014
24
0.030
Why?
Statistics as Topic
1
2014
147
0.030
Why?
Hippocampus
1
2015
240
0.030
Why?
Age of Onset
1
2014
171
0.030
Why?
Mice, Inbred C57BL
1
2020
3193
0.030
Why?
DNA, Viral
1
2014
228
0.030
Why?
Riluzole
1
2012
7
0.030
Why?
Occupational Therapy
1
2012
12
0.030
Why?
Arm
1
2012
38
0.030
Why?
Physical Therapy Modalities
1
2012
45
0.030
Why?
Antiretroviral Therapy, Highly Active
1
2012
94
0.030
Why?
Pregnancy
1
2020
2354
0.030
Why?
Sensitivity and Specificity
1
2015
1094
0.030
Why?
Neuroprotective Agents
1
2012
72
0.020
Why?
Interferon-gamma
1
2014
542
0.020
Why?
Epigenesis, Genetic
1
2015
351
0.020
Why?
Viral Load
1
2012
229
0.020
Why?
Acute Disease
1
2014
658
0.020
Why?
Amyotrophic Lateral Sclerosis
1
2016
476
0.020
Why?
Transcription, Genetic
1
2015
847
0.020
Why?
Aged, 80 and over
1
2020
5098
0.020
Why?
Child, Preschool
1
2015
1839
0.020
Why?
Psychiatric Status Rating Scales
1
2011
384
0.020
Why?
Risk Assessment
1
2014
1913
0.020
Why?
United States
1
2020
7516
0.020
Why?
Time Factors
1
2014
3578
0.020
Why?
Ionete's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (229)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_